Intravenous Valproate Sodium (Depacon) Aborts Migraine Rapidly: A Preliminary Report

Abstract

Intravenous valproate appears to be safe and effective for the acute treatment of migraine. Double-blind, placebo-controlled studies to further investigate the use of this agent in acute treatment of migraine attacks are warranted.